Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Google Scholar citation report
Citations : 1556

Journal of Pain & Relief received 1556 citations as per Google Scholar report

Journal of Pain & Relief peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Open J Gate
  • Genamics JournalSeek
  • Cosmos IF
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
Share This Page

Peng Y

Department of Neurology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China

Biography

Ying Peng has completed his Ph.D at the age of 31 years old from Schoolof Medicine, Sun Yat-Sen University,Guangzhou,China and finished his postdoctoral traininginNational Cancer Institute-at Frederick, NIH, MD, USA. He is aDirector and Professor of Department of Neurology, Sun Yat-Sen Memorial Hospital, SunYat-Sen University. As a clinical neurologist,he has published more than 85 papers in reputed journals and serving as an Associate- Editor-in-Chief of “Chinese Journal of Nervous and Mental Disease” , Deputy- Chief of Neuro-pharmacologicalAssociation of Guangdong province, and Deputy- Chief of Neurological division of Doctor Association of Guangdong province,China.
Publications

A Multicenter Study on Neuropathic Pain in China: Characteristics and the Efficacy of Pregabalin

Background: This clinical study aims to analyse the characteristics of neuropathic pain patients across country nationwide and evaluate the efficacy and tolerability of pregabalin for the treatment of neuropathic pain. The GABA analogue, pregabalin, is being studied to try to establish standardized management of neuropathic pain as it is commonly u... Read More»

He L, Yan ZW, Shen QY, Wang YD and Peng Y

: J Pain Relief 2019, 8: 340

DOI: 10.4172/2167-0846.1000340

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

Relevant Topics
Top